
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
Cepheid and its parent company Danaher announced today that they are reducing the price of the Xpert MTB/RIF test for TB by 20 percent in high-TB-burden countries from US$9.98 to $7.97 per test. This reduction is